112 related articles for article (PubMed ID: 2007419)
1. Serum iron as a tumor marker in renal cell carcinoma.
Yu CC; Chen KK; Chen MT; Huang JK; Lin AT; Lee YH; Chang LS
Eur Urol; 1991; 19(1):54-8. PubMed ID: 2007419
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of serum aldolase A in patients with renal cell carcinoma.
Takashi M; Zhu Y; Nakano Y; Miyake K; Kato K
Urol Res; 1992; 20(4):307-11. PubMed ID: 1509638
[TBL] [Abstract][Full Text] [Related]
3. Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor volume.
Partin AW; Criley SR; Steiner MS; Hsieh K; Simons JW; Lumadue J; Carter HB; Marshall FF
Urology; 1995 Feb; 45(2):211-7. PubMed ID: 7855968
[TBL] [Abstract][Full Text] [Related]
4. Serum ferritin: a tumor marker for renal cell carcinoma.
Essen A; Ozen H; Ayhan A; Ergen A; Tasar C; Remzi F
J Urol; 1991 Jun; 145(6):1134-7. PubMed ID: 2033679
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of gamma-enolase as a tumor marker for renal cell carcinoma.
Takashi M; Haimoto H; Tanaka J; Murase T; Kato K
J Urol; 1989 Apr; 141(4):830-4. PubMed ID: 2648028
[TBL] [Abstract][Full Text] [Related]
6. Serum immunosuppressive acidic protein as a tumor marker for renal cell carcinoma.
Igarashi T; Murakami S; Isaka S; Okano T; Shimazaki J; Matsuzaki O
Eur Urol; 1991; 19(4):332-5. PubMed ID: 1915542
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic value of serum immunosuppressive acidic protein in renal cell carcinoma].
Matsumoto K; Iwamura M; Muramoto M; Suyama K; Tabata K; Minei S; Hirai S; Baba S
Nihon Hinyokika Gakkai Zasshi; 2002 May; 93(4):548-54. PubMed ID: 12056039
[TBL] [Abstract][Full Text] [Related]
8. Soluble Ligand of the Immune Checkpoint Receptor (sPD-L1) in Blood Serum of Patients with Renal Cell Carcinoma.
Kushlinskii NE; Gershtein ES; Morozov AA; Goryacheva IO; Filipenko ML; Alferov AA; Bezhanova SD; Bazaev VV; Kazantseva IA
Bull Exp Biol Med; 2019 Jan; 166(3):353-357. PubMed ID: 30627905
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin in renal cell carcinoma: evaluation of its usefulness as a tumor marker.
Ljungberg B; Rasmuson T; Grankvist K
Eur Urol; 1992; 21(2):160-3. PubMed ID: 1499617
[TBL] [Abstract][Full Text] [Related]
10. Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor size and volume.
Kirkali Z; Güzelsoy M; Mungan MU; Kirkali G; Yörükoglu K
Urol Int; 1999; 62(1):21-5. PubMed ID: 10436426
[TBL] [Abstract][Full Text] [Related]
11. [Serum ferritin determination: is it useful in the early diagnosis of renal carcinoma?].
D'Addessi A; Racioppi M; Zappacosta B; Fanasca A; De Michele T; Alcini E
Arch Ital Urol Androl; 1997 Dec; 69(5):283-6. PubMed ID: 9477611
[TBL] [Abstract][Full Text] [Related]
12. Serum iron: a tumour marker in renal carcinoma.
Loughlin KR; Gittes RF
Br J Urol; 1986 Dec; 58(6):617-20. PubMed ID: 3801817
[TBL] [Abstract][Full Text] [Related]
13. Serum immunosuppressive acidic protein in renal cell carcinoma.
Ueda T
Urol Res; 1986; 14(2):101-3. PubMed ID: 3727211
[TBL] [Abstract][Full Text] [Related]
14. Serum tissue factor as a biomarker for renal clear cell carcinoma.
Silva DD; Noronha JAP; Pinheiro da Costa BE; Zandona PCE; Carvalhal GF
Int Braz J Urol; 2018; 44(1):38-44. PubMed ID: 28727370
[TBL] [Abstract][Full Text] [Related]
15. Serum amyloid a as an independent prognostic factor for renal cell carcinoma--a hospital based study from the Western region of Nepal.
Mittal A; Poudel B; Pandeya DR; Gupta SP; Sathian B; Yadav SK
Asian Pac J Cancer Prev; 2012; 13(5):2253-5. PubMed ID: 22901203
[TBL] [Abstract][Full Text] [Related]
16. Serum level of immunosuppressive acidic protein in haemodialysis patients with or without renal cell carcinoma.
Sasagawa I; Nakada T; Kubota Y; Suzuki H; Sawamura T
Br J Urol; 1994 Apr; 73(4):355-7. PubMed ID: 8199820
[TBL] [Abstract][Full Text] [Related]
17. Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma.
Guðbrandsdottir G; Hjelle KM; Frugård J; Bostad L; Aarstad HJ; Beisland C
Scand J Urol; 2015; 49(5):388-94. PubMed ID: 25773545
[TBL] [Abstract][Full Text] [Related]
18. Kidney Injury Molecule-1 (KIM-1) in Blood Plasma of Patients with Clear-Cell Carcinoma.
Kushlinskii NE; Gershtein ES; Naberezhnov DS; Taipov MA; Bezhanova SD; Pushkar' DY; Matveev VB; Stilidi IS
Bull Exp Biol Med; 2019 Jul; 167(3):388-392. PubMed ID: 31346876
[TBL] [Abstract][Full Text] [Related]
19. The Relationship Between Red Cell Distribution Width and Cancer-Specific Survival in Patients With Renal Cell Carcinoma Treated With Partial and Radical Nephrectomy.
Życzkowski M; Rajwa P; Gabrys E; Jakubowska K; Jantos E; Paradysz A
Clin Genitourin Cancer; 2018 Jun; 16(3):e677-e683. PubMed ID: 29339043
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of serum S100ao protein in patients with renal cell carcinoma].
Morita T; Kikuchi T; Hashimoto S; Goto K; Tozuka K; Tokue A; Kato K; Kimura S
Nihon Hinyokika Gakkai Zasshi; 1990 Aug; 81(8):1162-7. PubMed ID: 2232407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
